Burkina Faso / Creation of a pharmaceutical technology park: President Ibrahim Traoré gives concrete expression to his vision for his country’s healthcare autonomy
President Ibrahim Traoré continues to assert his vision for a prosperous and self-reliant Burkina Faso with a landmark initiative announced at Wednesday’s Council of Ministers.
The establishment of the Kokologho Integrated Pharmaceutical Technopole Management Company marks a strategic shift aimed at strengthening the nation’s independence in pharmaceutical production.
The Kokologho Technopole will serve as a vital industrial hub, dedicated to research, innovation, and the large-scale production of pharmaceuticals. This specialized zone will drive local entrepreneurship and foster innovation in the healthcare sector.
By boosting national pharmaceutical manufacturing, this initiative aims to reduce reliance on imports and ensure broader access to quality medications for the people of Burkina Faso.
Beyond its industrial focus, this project underscores President Traoré’s commitment to creating local jobs and improving the country’s healthcare system.
The technopole is a direct response to the pressing challenge of achieving health sovereignty, a key objective for the nation’s future.
With this bold move, President Traoré continues to advance his ambition of building a forward-thinking Burkina Faso, where economic and social development are top priorities.
The Kokologho Pharmaceutical Technopole stands as a symbol of progress, enhancing both the country’s healthcare independence and its industrial potential, further cementing Burkina Faso’s path towards sustainable growth and self-sufficiency.
Papa IBRAHIMA
